Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
OrthoPediatrics
(NASDAQ:KIDS)
Intraday
$32.02
0.23
[0.72%]
After-Hours
$32.02
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$32.02
0.23
[0.72%]
At close: May 17
$32.02
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for OrthoPediatrics Stock (NASDAQ:KIDS)
OrthoPediatrics Stock (NASDAQ: KIDS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 08, 2024
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $38
Benzinga Newsdesk
-
May 8, 2024, 9:01AM
Tuesday, May 07, 2024
Expert Ratings For OrthoPediatrics
Benzinga Insights
-
May 7, 2024, 3:00PM
Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $42
Benzinga Newsdesk
-
May 7, 2024, 1:43PM
JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
Benzinga Newsdesk
-
May 7, 2024, 11:39AM
Monday, May 06, 2024
OrthoPediatrics Sees FY24 Revenue $200M-$203M Vs $198.125M Estimate
Benzinga Newsdesk
-
May 6, 2024, 4:54PM
OrthoPediatrics Q1 2024 Adj EPS $(0.30) Beats $(0.40) Estimate, Sales $44.685M Beat $41.775M Estimate
Benzinga Newsdesk
-
May 6, 2024, 4:29PM
Thursday, May 02, 2024
OrthoPediatrics Corp. Receives "Breakthrough Device" Designation From FDA For eLLi Growing Rod System For Pediatric Patients With Scoliosis
Benzinga Newsdesk
-
May 2, 2024, 5:12PM
Wednesday, April 10, 2024
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Benzinga Insights
-
Apr 10, 2024, 5:01PM
Needham Reiterates Buy on OrthoPediatrics, Maintains $37 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 10:46AM
Friday, March 08, 2024
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $32
Benzinga Newsdesk
-
Mar 8, 2024, 9:19AM
Thursday, March 07, 2024
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
Benzinga Insights
-
Mar 7, 2024, 4:00PM
Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $34
Benzinga Newsdesk
-
Mar 7, 2024, 4:00PM
Needham Reiterates Buy on OrthoPediatrics, Maintains $37 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 12:11PM
OrthoPediatrics shares are trading higher after the company reported better-than-expected Adj. EPS results and reiterated FY24 revenue guidance above estimates.
Benzinga Newsdesk
-
Mar 7, 2024, 11:29AM
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Mar 7, 2024, 10:23AM
JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 10:15AM
Wednesday, March 06, 2024
OrthoPediatrics Reiterates 2024 Guidance Range $197M-$200M vs $182.9M Est.
Benzinga Newsdesk
-
Mar 6, 2024, 4:38PM
OrthoPediatrics Q4 2023 Adj EPS $(0.230) Beats $(0.280) Estimate, Sales $37.613M Miss $37.733M Estimate
Benzinga Newsdesk
-
Mar 6, 2024, 4:10PM
Recap: OrthoPediatrics Q4 Earnings
Benzinga Insights
-
Mar 6, 2024, 4:10PM
Earnings Scheduled For March 6, 2024
Benzinga Insights
-
Mar 6, 2024, 5:00AM
Tuesday, March 05, 2024
Earnings Outlook For OrthoPediatrics
Benzinga Insights
-
Mar 5, 2024, 10:05AM
Monday, March 04, 2024
OrthoPediatrics Launches RESPONSE Rib And Pelvic Fixation System For EOS Scoliosis
Benzinga Newsdesk
-
Mar 4, 2024, 4:10PM
Thursday, January 25, 2024
Decoding 5 Analyst Evaluations For OrthoPediatrics
Benzinga Insights
-
Jan 25, 2024, 7:00AM
Truist Securities Downgrades OrthoPediatrics to Hold, Lowers Price Target to $31
Benzinga Newsdesk
-
Jan 25, 2024, 6:43AM
Monday, January 08, 2024
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights For Q4 & FY23; Sees Q4 Revenue $37.6M Vs $37.77M Est.; FY23 Revenue $148.7M Vs $148.88M Est.; Sees FY24 Revenue $197M-$200M Vs $177.7M Est
Benzinga Newsdesk
-
Jan 8, 2024, 8:23AM
OrthoPediatrics Corp. Announces Acquisition Of Boston Orthotics & Prosthetics For An Upfront Cash Payment Of $22M; Closes $80M Debt Financing To Support Acquisition And Future Business Requirements
Benzinga Newsdesk
-
Jan 8, 2024, 8:20AM
Friday, December 22, 2023
Truist Securities Maintains Buy on OrthoPediatrics, Raises Price Target to $39
Benzinga Newsdesk
-
Dec 22, 2023, 10:00AM
Thursday, December 07, 2023
Analyst Ratings for OrthoPediatrics
Benzinga Insights
-
Dec 7, 2023, 2:00PM
JMP Securities Maintains Market Outperform on OrthoPediatrics, Lowers Price Target to $50
Benzinga Newsdesk
-
Dec 7, 2023, 1:18PM
Wednesday, November 08, 2023
Truist Securities Maintains Buy on OrthoPediatrics, Raises Price Target to $35-Report Released on 7th Nov
Benzinga Newsdesk
-
Nov 8, 2023, 10:40AM
Truist Securities Maintains Buy on OrthoPediatrics, Raises Price Target to $35
Benzinga Newsdesk
-
Nov 8, 2023, 10:19AM
Tuesday, November 07, 2023
Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $37
Benzinga Newsdesk
-
Nov 7, 2023, 1:30PM
Monday, November 06, 2023
OrthoPediatrics Sees FY23 Revenue $148M-$152M Vs $149.17M Est.
Benzinga Newsdesk
-
Nov 6, 2023, 4:26PM
OrthoPediatrics Q3 EPS $(0.13) Beats $(0.22) Estimate, Sales $39.97M Miss $40.37M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:25PM
Earnings Scheduled For November 6, 2023
Benzinga Insights
-
Nov 6, 2023, 8:24AM
OrthoPediatrics Corp. Enters Distribution Agreement With Ora Medical To Sell Ora Medical's Levity Gait Trainer
Benzinga Newsdesk
-
Nov 6, 2023, 8:10AM
Thursday, October 19, 2023
OrthoPediatrics Launches Pediatric Nailing Platform, TIBIA; Received FDA Clearance In Sept. 2023
Benzinga Newsdesk
-
Oct 19, 2023, 8:10AM
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 10, 2023, 1:09PM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Lisa Levin
-
Oct 4, 2023, 8:12AM
BTIG Maintains Buy on OrthoPediatrics, Lowers Price Target to $52
Benzinga Newsdesk
-
Oct 4, 2023, 5:14AM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Monday, September 11, 2023
OrthoPediatrics Secures FDA 510(k) Clearance For Pediatric Nailing Platform | Tibia
Benzinga Newsdesk
-
Sep 11, 2023, 4:09PM
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 11, 2023, 1:38PM
Friday, September 01, 2023
4 Analysts Have This to Say About OrthoPediatrics
Benzinga Insights
-
Sep 1, 2023, 11:00AM
JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $60 Price Target
Benzinga Newsdesk
-
Sep 1, 2023, 8:29AM
Monday, August 14, 2023
OrthoPediatrics Insider Trades Send a Signal
Benzinga Insights
-
Aug 14, 2023, 11:00AM
Wednesday, August 09, 2023
OrthoPediatrics Director Acquires 670 Shares After Exercising Company Stock Options
Benzinga Insights
-
Aug 9, 2023, 11:00AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch